Wanbury — 360° view

Wanbury, a company in the Pharmaceuticals industry, reported revenue of ₹183 crore and net profit of ₹12 crore for the September 2026 quarter.

Wanbury (NSE: WANBURY) closed at ₹179.37 on 20 Nov 2026, down 22.1% over the past year. Its market capitalisation is ₹627 crore and it trades at 11.2 times earnings.

Share price
₹179.37 (20 Nov 2026)
Market cap
₹627 Cr (20 Nov 2026)
P/E
11.19 (20 Nov 2026)
Revenue
₹183 Cr (September 2026 quarter)
Net profit
₹12 Cr (September 2026 quarter)
ROCE
30.7% (FY26)
ROE
68.4% (FY26)
Book value
₹45.7 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹358.85 / ₹161.50 (20 Nov 2026)
1-year return
-22.1% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: WANBURY

Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.